These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 9053852

  • 1. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer.
    Wolf G, Elez R, Doermer A, Holtrich U, Ackermann H, Stutte HJ, Altmannsberger HM, Rübsamen-Waigmann H, Strebhardt K.
    Oncogene; 1997 Feb 06; 14(5):543-9. PubMed ID: 9053852
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck.
    Knecht R, Elez R, Oechler M, Solbach C, von Ilberg C, Strebhardt K.
    Cancer Res; 1999 Jun 15; 59(12):2794-7. PubMed ID: 10383133
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancer.
    Wang ZX, Xue D, Liu ZL, Lu BB, Bian HB, Pan X, Yin YM.
    Int J Biochem Cell Biol; 2012 Jan 15; 44(1):200-10. PubMed ID: 22064247
    [Abstract] [Full Text] [Related]

  • 4. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
    Adachi M, Taki T, Ieki Y, Huang CL, Higashiyama M, Miyake M.
    Cancer Res; 1996 Apr 15; 56(8):1751-5. PubMed ID: 8620488
    [Abstract] [Full Text] [Related]

  • 5. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
    Marchetti A, Bertacca G, Buttitta F, Chella A, Quattrocolo G, Angeletti CA, Bevilacqua G.
    Clin Cancer Res; 1999 Aug 15; 5(8):2077-81. PubMed ID: 10473089
    [Abstract] [Full Text] [Related]

  • 6. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J, Muley T, Hoffmann H, Bülzebruck H, Dienemann H.
    Dtsch Med Wochenschr; 2006 Nov 24; 131(47):2643-8. PubMed ID: 17109272
    [Abstract] [Full Text] [Related]

  • 7. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM, Weissfeld LA, Singh-Kaw P, Weyant RJ, Testa JR, Landreneau RJ.
    Cancer Res; 1997 Feb 01; 57(3):433-9. PubMed ID: 9012470
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 01; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.
    Kim SH, Choi HY, Lee J, Son DS, Lee HS, Song IS, Lim YS, Hong YS, Kim J, Choi YS.
    J Surg Oncol; 2007 Mar 15; 95(4):337-46. PubMed ID: 17326127
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.
    Chang YS, Wang L, Liu D, Mao L, Hong WK, Khuri FR, Lee HY.
    Clin Cancer Res; 2002 Dec 15; 8(12):3669-75. PubMed ID: 12473575
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F, Dosaka-Akita H, Mishina T, Nishi M, Kojima T, Hiroumi H, Ogura S, Shimizu M, Katoh H, Kawakami Y.
    Clin Cancer Res; 2000 Oct 15; 6(10):4073-81. PubMed ID: 11051259
    [Abstract] [Full Text] [Related]

  • 18. Prognostic influence of loss of blood group A antigen expression in pathologic stage I non-small-cell lung cancer.
    León-Atance P, Moreno-Mata N, González-Aragoneses F, Cañizares-Carretero MÁ, Poblet-Martínez E, Genovés-Crespo M, García-Jiménez MD, Honguero-Martínez AF, Rombolá CA, Simón-Adiego CM, Peñalver-Pacual R, Alvarez-Fernández E.
    Arch Bronconeumol; 2012 Feb 15; 48(2):49-54. PubMed ID: 22153581
    [Abstract] [Full Text] [Related]

  • 19. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G.
    Cancer; 2005 Apr 15; 103(8):1676-84. PubMed ID: 15754326
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.